ClinicalTrials.govpublic full text
Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis
pancreatic ductal adenocarcinoma (pdac), peritoneal carcinomatosis, pancreatic adenocarcinoma, pancreatic ductal adenocarcinoma, pdac, metastatic, nalirifox, intraperitoneal chemotherapy, intraperitoneal paclitaxel, circulating tumor dna (ctdna), peritoneal cell-free dna, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 884239
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.